Cargando…
Docetaxel-associated myalgia–arthralgia syndrome in patients with breast cancer
BACKGROUND: As taxanes are increasingly used in oncology, the myalgia–arthralgia syndrome (M-AS) that represents an adverse effect of these drugs is becoming more common. Nevertheless, information regarding predisposing factors, prevention, and therapy of the syndrome is still lacking. PATIENTS AND...
Autores principales: | Seguin, Chelsea, Kovacevich, Natalie, Voutsadakis, Ioannis A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271389/ https://www.ncbi.nlm.nih.gov/pubmed/28176956 http://dx.doi.org/10.2147/BCTT.S124646 |
Ejemplares similares
-
Myalgia-arthralgia syndrome induced by docetaxel in oncology: the wolf disguised as a sheep
por: Cidon, Esther Una
Publicado: (2018) -
Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial
por: Ângelo, David Faustino, et al.
Publicado: (2023) -
Purtscher-like retinopathy as presenting manifestation of systemic lupus erythromatosus following high-grade fever with myalgia and arthralgia
por: Palkar, Amit H, et al.
Publicado: (2018) -
Fulminating septic shock from Clostridium perfringens in an early breast cancer patient with severe myalgia after docetaxel treatment
por: Minisini, Alessandro Marco, et al.
Publicado: (2011) -
Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
por: Romero, Sally A.D., et al.
Publicado: (2019)